NasdaqGM - Nasdaq Real Time Price USD
Castle Biosciences, Inc. (CSTL)
20.95
-0.32
(-1.50%)
As of 2:46:53 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 6 | 7 |
| Avg. Estimate | -0.07 | -0.37 | -1.43 | -1.79 |
| Low Estimate | -0.31 | -0.46 | -1.67 | -2.62 |
| High Estimate | 0.1 | -0.23 | -1.09 | -1.02 |
| Year Ago EPS | -0.09 | 0.31 | 0.62 | -1.43 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 80.37M | 71.82M | 288.81M | 297.48M |
| Low Estimate | 69.2M | 69.5M | 287M | 275.4M |
| High Estimate | 85.25M | 73.9M | 291.2M | 312.8M |
| Year Ago Sales | 72.97M | 87M | 332.07M | 288.81M |
| Sales Growth (year/est) | 10.14% | -17.45% | -13.03% | 3.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.31 | -0.25 | 0.01 | 0.04 |
| EPS Actual | -0.09 | 0.31 | 0.08 | 0.32 |
| Difference | 0.22 | 0.55 | 0.07 | 0.28 |
| Surprise % | 71.20% | 226.53% | 966.67% | 700.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.37 | -1.43 | -1.79 |
| 7 Days Ago | -0.07 | -0.37 | -1.43 | -1.79 |
| 30 Days Ago | -0.07 | -0.37 | -1.44 | -1.79 |
| 60 Days Ago | -0.51 | -0.5 | -1.61 | -1.38 |
| 90 Days Ago | -0.62 | -0.49 | -1.73 | -1.35 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | -- |
| Up Last 30 Days | 1 | 1 | 3 | 1 |
| Down Last 7 Days | 1 | 1 | -- | 1 |
| Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CSTL | 26.99% | -218.89% | -330.91% | -24.83% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 2/28/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 1/2/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 11/6/2024 |
| Maintains | Lake Street: Buy to Buy | 11/5/2024 |
| Maintains | Keybanc: Overweight to Overweight | 11/5/2024 |
| Maintains | Baird: Outperform to Outperform | 11/5/2024 |
Related Tickers
BDSX Biodesix, Inc.
0.5850
+18.13%
FLGT Fulgent Genetics, Inc.
18.88
-0.13%
VCYT Veracyte, Inc.
32.00
+1.70%
CDNA CareDx, Inc
18.29
+2.52%
IDXG Interpace Biosciences, Inc.
1.0000
0.00%
RNVA Rennova Health, Inc.
0.0001
0.00%
AVCR.V Avricore Health Inc.
0.0550
+22.22%
GH Guardant Health, Inc.
46.68
+2.27%
TWST Twist Bioscience Corporation
39.78
+5.74%
IZOZF Izotropic Corporation
0.1650
0.00%